Page 3 - Robertj Fox News Today

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in February 25.01.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific and Investor Conferences in February N...

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Industry Conferences in October 04.10.2022 / 12:30 CET/CEST The issuer is solely responsible

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Industry Conferences in October 04.10.2022 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific and Industry Conferences in October NEW...

04.10.2022 - Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Industry Conferences in October 04.10.2022 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in ... Seite 1

Issuer: Immunic, Inc. / Key word(s): Scientific publication/Study results Immunic Announces Publication of Data From Its Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting

NEW YORK, June 15, 2022 /PRNewswire/ -- Immunic, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic... | June 15, 2022

A B-cell count of at least 40/µL is necessary to mount an adequate antibody response to COVID-19 boosters in patients with multiple sclerosis, new research shows.

NIH-funded trial offers hope for disease with limited treatment options

DGAP-News: Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April vom 13.04.2021, 12:30 Uhr Bild: pixabay.com Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April 13.04.2021 / 12:30 Immunic, Inc. to Participate in Scientific, Investor and Industry Conferences in April NEW YORK, April 13, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapie...